‘Concealed’ antigens: Expanding the range of immunological targets
Parasitology Today, ISSN: 0169-4758, Vol: 9, Issue: 4, Page: 132-135
1993
- 66Citations
- 21Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations66
- Citation Indexes66
- 66
- CrossRef62
- Captures21
- Readers21
- 21
Article Description
For many parasites, the interaction between the immunogenicity of the parasite and the immunological response of the host is a dynamic equilibrium that allows both to survive, albeit often with severe consequences for the host. Vaccines, if intended as a means of parasite control, are unlikely to be generally successful if they do no more than mimic an immunological equilibrium that would be reached after natural exposure to the parasites. The situation must be tipped in favour of the host. It has been difficult to find ways around this impasse. One approach has been receiving practical attention over recent years, an approach that Peter Willadsen, Craig Eisemann and Ross Tellam have called vaccination against ‘concealed’ antigens.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/016947589390177H; http://dx.doi.org/10.1016/0169-4758(93)90177-h; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0027479701&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/15463735; https://linkinghub.elsevier.com/retrieve/pii/016947589390177H; http://linkinghub.elsevier.com/retrieve/pii/016947589390177H; http://api.elsevier.com/content/article/PII:016947589390177H?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:016947589390177H?httpAccept=text/plain; http://dx.doi.org/10.1016/0169-4758%2893%2990177-h; https://dx.doi.org/10.1016/0169-4758%2893%2990177-h
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know